-
11.
公开(公告)号:US10519147B2
公开(公告)日:2019-12-31
申请号:US16061815
申请日:2016-12-15
Applicant: Merck Sharp & Dohme Corp. , Thomas J. Greshock , James Mulhearn , Liangqin Guo , Ting Zhang , Deping Wang , Ronald M. Kim , Mark E. Layton , Michael J. Kelly, III , Rajan Anand , Philippe Nantermet , Tianying Jian , Anthony J. Roecker , Walter Won , Gang Zhou
Inventor: Thomas J. Greshock , James Mulhearn , Liangqin Guo , Ting Zhang , Deping Wang , Ronald M. Kim , Mark E. Layton , Michael J. Kelly, III , Rajan Anand , Philippe Nantermet , Tianying Jian , Anthony J. Roecker , Walter Won , Gang Zhou
IPC: C07D417/12 , A61K45/06 , C07D277/52 , C07D285/135 , A61P25/02 , A61P25/04 , A61P11/14 , A61P17/04
Abstract: Disclosed are compounds of Formula A, or a salt thereof, where Q, X, R1 and R2 are as defined herein, which compounds have properties for inhibiting Nav 1.7 ion channels found in peripheral and sympathetic neurons. Also described are pharmaceutical formulations comprising the compounds of Formula A or their salts, and methods of treating pain (acute, post-operative, neuropathic), or cough or itch disorders using the same.
-
公开(公告)号:US09708308B2
公开(公告)日:2017-07-18
申请号:US14652237
申请日:2013-12-16
Inventor: Cameron James Smith , John Qiang Tan , Ting Zhang , James Balkovec , William John Greenlee , Liangqin Guo , Yi-Heng Chen , Yili Chen , Jiayi Xu , Samuel Chackalamannil , Tomokazu Hirabayashi , Hiroshi Nagasue , Kouki Ogawa
IPC: C07D471/04 , C07D413/14 , C07D417/14 , C07D487/04 , C07D498/04
CPC classification number: C07D413/14 , C07D417/14 , C07D471/04 , C07D487/04 , C07D498/04
Abstract: The present invention provides a compound of Formula (I) wherein R1 is H or C1-6 alkyl, R2, is H or C1-6 alkyl or CH2OH, R3 is H or C1-6 alkyl, and R4 is H or C1-6 alkyl, provided that when R1, R2, and R3 are H, R4 is C1-6 alkyl, and when R1, R2, and R4 are H, then R3 is C1-6 alkyl, and when R1, R3, and R4 are H, R2 is C1-6 alkyl or —CH2OH, and when R2, R3, and R4 are H, then R1 is C1-6 alkyl; A is 1) a 9-10 membered bicyclic heterocycle having 1-3 heteroatoms independently selected from N, S and O, which 9-10 membered bicyclic heterocycle is unsubstituted or substituted with R5 and unsubstituted or substituted with R6 and unsubstituted or substituted with NH2, or 2) a 6-9 membered monocyclic or bicyclic carbocyclic ring system unsubstituted or substituted with R5, unsubstituted or substituted with R6, and unsubstituted or substituted with —CH2NH2; and B is 1) a 5- or 6-membered monocyclic heterocycle having 1 or 2 heteroatoms independently selected from N, S or O, which is unsubstituted or substituted on a carbon or nitrogen atom with R7, unsubstituted or substituted on a carbon or nitrogen atom with R8, and unsubstituted or substituted on a carbon or nitrogen atom with R9, or 2) an 8- or 9-membered fused bicyclic heterocycle having 1, 2 or 3 nitrogen atoms which is unsubstituted or substituted on a carbon or nitrogen atom with R7, and unsubstituted or substituted on a carbon or nitrogen atom with R8; and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing thromboses.
-
公开(公告)号:US20190233406A1
公开(公告)日:2019-08-01
申请号:US16246068
申请日:2019-01-11
Applicant: Merck Sharp & Dohme Corp.
Inventor: Thomas J. Greshock , James Mulhearn , Junying Zheng , Ronald M. Kim , Ting Zhang , Anthony J. Roecker , Walter Won , Philippe Nantermet , Rajan Anand , Gang Zhou , Deping Wang , Liangqin Guo
IPC: C07D417/12 , A61K31/426 , A61K31/433 , A61K31/427 , A61K31/551 , C07D277/52 , C07D285/08 , A61K45/06
CPC classification number: C07D417/12 , A61K31/426 , A61K31/427 , A61K31/433 , A61K31/551 , A61K45/06 , C07D277/52 , C07D285/08 , A61K2300/00
Abstract: Disclosed are compounds of Formula A, or a salt thereof: wherein R1, R2, and E are defined herein, which compounds have properties for inhibiting Nav 1.7 ion channels found in peripheral and sympathetic neurons. Also described are pharmaceutical formulations comprising the compounds of Formula A or their salts, and methods of treating pain disorders, cough, and itch using the same.
-
14.
公开(公告)号:US10442778B2
公开(公告)日:2019-10-15
申请号:US16086654
申请日:2017-03-17
Applicant: Merck Sharp & Dohme Corp.
Inventor: Anthony J. Roecker , Mark E. Layton , Thomas J. Greshock , Joseph E. Pero , Michael J. Kelly, III , Ting Zhang
IPC: C07D277/52 , C07D285/08 , A61K31/635 , A61K45/06 , A61K31/18 , A61K31/427 , A61K31/426 , A61K31/433 , C07F7/08
Abstract: Disclosed are compounds of Formula A-1, or a salt thereof: Formula A-1, where J, K, Q and R1 are as defined herein, which compounds have properties for inhibiting sodium ion channels found in peripheral and sympathetic neurons. Also described are pharmaceutical formulations comprising the compounds of Formula A-1 or their salts, and methods of treating pain (e.g. chronic pain), or cough or itch disorders using the same.
-
15.
公开(公告)号:US20180362518A1
公开(公告)日:2018-12-20
申请号:US16061815
申请日:2016-12-15
Applicant: Thomas J. GRESHOCK , James MULHEARN , Liangqin GUO , Ting ZHANG , Deping WANG , Ronald M. KIM , Mark E. LAYTON , Michael J. KELLY, III , Rajan ANAND , Tianying JIAN , Philippe NANTERMET , Anthony J. ROECKER , Walter WON , Gang ZHOU , Merck Sharp & Dohme Corp.
Inventor: Thomas J. Greshock , James Mulhearn , Liangqin Guo , Ting Zhang , Deping Wang , Ronald M. Kim , Mark E. Layton , Michael J. Kelly, III , Rajan Anand , Philippe Nantermet , Tianying Jian , Anthony J. Roecker , Walter Won , Gang Zhou
IPC: C07D417/12 , C07D285/135 , C07D277/52 , A61P11/14 , A61P17/04 , A61P25/04 , A61P25/02
CPC classification number: C07D417/12 , A61K45/06 , A61P11/14 , A61P17/04 , A61P25/02 , A61P25/04 , C07D277/52 , C07D285/135
Abstract: Disclosed are compounds of Formula A, or a salt thereof, where Q, X, R1 and R2 are as defined herein, which compounds have properties for inhibiting Na 1.7 ion channels found in peripheral and sympathetic neurons. Also described are pharmaceutical formulations comprising the compounds of Formula A or their salts, and methods of treating pain (acute, post-operative, neuropathic), or cough or itch disorders using the same.
-
公开(公告)号:US20170174674A1
公开(公告)日:2017-06-22
申请号:US15378465
申请日:2016-12-14
Applicant: Merck Sharp & Dohme Corp.
Inventor: Thomas J. Greshock , James Mulhearn , Junying Zheng , Ronald M. Kim , Ting Zhang , Anthony J. Roecker , Walter Won , Philippe Nantermet , Rajan Anand , Gang Zhou , Deping Wang , Liangqin Guo
IPC: C07D417/12 , C07D277/52 , A61K31/551 , A61K31/427 , A61K31/433 , A61K31/426 , C07D285/08 , A61K45/06
CPC classification number: C07D417/12 , A61K31/426 , A61K31/427 , A61K31/433 , A61K31/551 , A61K45/06 , C07D277/52 , C07D285/08 , A61K2300/00
Abstract: Disclosed are compounds of Formula A, or a salt thereof: wherein R1, R2, and E are defined herein, which compounds have properties for inhibiting Nav 1.7 ion channels found in peripheral and sympathetic neurons. Also described are pharmaceutical formulations comprising the compounds of Formula A or their salts, and methods of treating pain disorders, cough, and itch using the same.
-
公开(公告)号:US20170027916A1
公开(公告)日:2017-02-02
申请号:US15303322
申请日:2015-04-10
Inventor: Isao Sakurada , Tomokazu Hirabayashi , Yoshitaka Maeda , Hiroshi Nagasue , Takashi Mizuno , Jiayi Xu , Ting Zhang , Cameron Smith , Dann Parker
IPC: A61K31/439 , A61K45/06 , A61K31/444 , A61K31/506 , A61K31/501 , C07D519/00 , C07D413/14 , C07D498/04
CPC classification number: A61K31/439 , A61K31/444 , A61K31/501 , A61K31/506 , A61K45/06 , C07D209/52 , C07D261/20 , C07D413/04 , C07D413/14 , C07D498/04 , C07D519/00
Abstract: In its many embodiments, the present invention provides a novel class of benzamide compounds represented by Formula (I) or pharmaceutically acceptable salts or solvates thereof, or pharmaceutical compositions comprising one or more said compounds or pharmaceutically acceptable salts or solvates thereof, and methods for using said compounds or pharmaceutically acceptable salts or solvates thereof for treating or preventing a thromboses, embolisms, hypercoagulability or fibrotic changes.
Abstract translation: 在其许多实施方案中,本发明提供了由式(I)表示的新一类苯甲酰胺化合物或其药学上可接受的盐或溶剂化物,或包含一种或多种所述化合物或其药学上可接受的盐或溶剂化物的药物组合物,以及使用 所述化合物或其药学上可接受的盐或溶剂合物用于治疗或预防血栓形成,栓塞,高凝状态或纤维变性。
-
公开(公告)号:US20150329562A1
公开(公告)日:2015-11-19
申请号:US14652174
申请日:2013-12-16
Applicant: MERCK SHARP & DOHME CORP.
Inventor: Cameron James Smith , John Qiang Tan , Ting Zhang , James Balkovec , William John Greenlee , Liangqin Guo , Yi-Heng Chen , Yili Chen , Samuel Chackalamannil , Tomokazu Hirabayashi , Mika Sekioka
IPC: C07D513/04 , C07D413/14
CPC classification number: C07D413/14 , C07D413/12 , C07D513/04
Abstract: The present invention provides a compound of Formula (I) wherein R1, R2, R3 and R4 are independently H or C1-6 alkyl, provided that when R1, R2, and R3 are H, R4 is C1-6 alkyl, and when R1, R2, and R4 are H, R3 is C1-6 alkyl, and when R1, R3, and R4 are H, R2 is C1-6 alkyl, and when R2, R3, and R4 are H, R is C1-6 alkyl; and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing thromboses, embolisms, hypercoagulability or fibrotic changes.
Abstract translation: 本发明提供式(I)的化合物,其中R 1,R 2,R 3和R 4独立地为H或C 1-6烷基,条件是当R 1,R 2和R 3为H时,R 4为C 1-6烷基, 中,R 2和R 4为H,R 3为C 1-6烷基,当R 1,R 3和R 4为H时,R 2为C 1-6烷基,当R 2,R 3和R 4为H时,R为C 1-6烷基 ; 和包含一种或多种所述化合物的药物组合物,以及使用所述化合物治疗或预防血栓形成,栓塞,高凝状态或纤维化改变的方法。
-
-
-
-
-
-
-